Evidence map›Paper›PMID 31160788›Full record

ArticleNature protocols2019

Derivation and maintenance of mouse haploid embryonic stem cells.

Ulrich Elling, Michael Woods, Josep V Forment, Beiyuan Fu, Fengtang Yang, Bee Ling Ng, Jose R Vicente, David J Adams, Brendan Doe, Stephen P Jackson and 2 more

Open access · greenAbstract read
In one paragraph

Article in Nature protocols, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Ulrich EllingInstitute of Molecular Biotechnology of the Austrian Academy of Science (IMBA), Vienna Biocenter (VBC), Vienna, Austria.ORCID http://orcid.org/0000-0002-4514-2809
Michael WoodsUK Dementia Research Institute at University of Cambridge and Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Josep V FormentDNA Damage Response Biology, Oncology Innovative Medicines, AstraZeneca, Cambridge, UK.
Beiyuan FuWellcome Trust Sanger Institute, Cambridge, UK.
Fengtang YangWellcome Trust Sanger Institute, Cambridge, UK.ORCID http://orcid.org/0000-0002-3573-2354
Bee Ling NgWellcome Trust Sanger Institute, Cambridge, UK.ORCID http://orcid.org/0000-0002-8338-4390
Jose R VicenteUK Dementia Research Institute at University of Cambridge and Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
David J AdamsWellcome Trust Sanger Institute, Cambridge, UK.
Brendan DoeWellcome Trust Sanger Institute, Cambridge, UK.
Stephen P JacksonThe Wellcome Trust CRUK Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK.
Josef M PenningerInstitute of Molecular Biotechnology of the Austrian Academy of Science (IMBA), Vienna Biocenter (VBC), Vienna, Austria. josef.penninger@ubc.ca.
Gabriel BalmusUK Dementia Research Institute at University of Cambridge and Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. gb318@cam.ac.uk.ORCID http://orcid.org/0000-0003-2872-4468
Wellcome Sanger Institute · GBUniversity of Cambridge · GBInstitute of Molecular Biotechnology · ATAstraZeneca (United Kingdom) · GB

Funding

Cancer Research UK 14356Cancer Research UK 18796Cancer Research UK 21717Cancer Research UK A14492Cancer Research UK A18796Cancer Research UK C6946/A14492Cancer Research UK C6/A18796European Research Council 233407Medical Research Council MC_PC_17111Wellcome Trust 092096Wellcome Trust 098051Wellcome Trust 206388Wellcome Trust 206388/Z/17/ZWellcome Trust WT098051
6 · The paper itself

Abstract

Ploidy represents the number of chromosome sets in a cell. Although gametes have a haploid genome (n), most mammalian cells have diploid genomes (2n). The diploid status of most cells correlates with the number of probable alleles for each autosomal gene and makes it difficult to target these genes via mutagenesis techniques. Here, we describe a 7-week protocol for the derivation of mouse haploid embryonic stem cells (hESCs) from female gametes that also outlines how to maintain the cells once derived. We detail additional procedures that can be used with cell lines obtained from the mouse Haplobank, a biobank of >100,000 individual mouse hESC lines with targeted mutations in 16,970 genes. hESCs can spontaneously diploidize and can be maintained in both haploid and diploid states. Mouse hESCs are genomically and karyotypically stable, are innately immortal and isogenic, and can be derived in an array of differentiated cell types; they are thus highly amenable to genetic screens and to defining molecular connectivity pathways.

Indexed as

HaploidyAnimalsBlastocystCell Culture TechniquesCell LineCell SeparationFemaleMiceMice, Inbred C57BLMice, Inbred StrainsMouse Embryonic Stem CellsWorkflow

Identifiers

PMID31160788
PMCPMC6997032
OpenAlexW2948670875

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.